While it is well-established that KMT2A/MLL1 is commonly involved in pro-tumorigenic chromosomal translocations or rearrangement in leukemia [1], the frequency of KMT2/MLL genetic alterations and overexpression in other tumor types, including breast, prostate, pancreas, stomach, and colon, was surprising. Here, KMT2A is linked to leukemia.